Skip to main content

Advertisement

Erratum: Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma

Article metrics

The original article was published in BMC Medicine 2015 13:108

Author´s correction note

Upon reviewing our recently published research article [1], we noticed that some of the data presented in the manuscript and on the tables were incorrectly presented. These mistakes do not change the overall conclusions regarding the high accuracy of miR-203 and miR-205 as diagnostic markers of neck metastases in HNSCC.

Corrected text

1. (Page 8: End of “Validation and diagnostic accuracy of miR-203 and miR-205 expression in FNA samples”)

Please replace

All in all, the sensitivity rate for both markers was 92.9 % (39/42, CI 95 %, 80.5–98.4), with a specificity level of 100 % (71/71, CI 95 %, 94.9–100) (Table 2; Figure 6B).

Table 2 Sensitivity and specificity values of microRNAs evaluated in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA biopsies from lymph node samples

With the amended text

All in all, the sensitivity rate for both markers was 93.3 % (42/45, CI 95 %, 81.7–98.6), with a specificity level of 100 % (68/68, CI 95 %, 94.7–100) (Table 2; Figure 6B).

Table 2 Sensitivity and specificity values of microRNAs evaluated in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA biopsies from lymph node samples

2. (Page 8: End of “Validation and diagnostic accuracy of miR-203 and miR-205 expression in FNA samples”)

Please replace

Moreover, negative predictive values were of 95.9 % (95 % CI, 88.6–99.1 %) and positive predictive values of 100 % (95 % CI, 90.9–100 %) for both microRNAs (Table 3).

Table 3 Accuracy characteristics of microRNAs in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA biopsies from lymph node samples

With the amended text

Moreover, negative predictive values were of 95.9 % (95 % CI, 88.6–99.1 %) and positive predictive values of 100% (95 % CI, 91.5–100 %) for both microRNAs (Table 3).

Table 3 Accuracy characteristics of microRNAs in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA biopsies from lymph node samples

Reference

  1. 1.

    de Carvalho AC, Scapulatempo-Neto C, Maia DC, Evangelista AF, Morini MA, Carvalho AL, et al. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma. BMC Med. 2015;13(1):108. doi:10.1186/s12916-015-0350-3.

Download references

Author information

Correspondence to André Lopes Carvalho or André Luiz Vettore.

Additional information

The online version of the original article can be found under doi:10.1186/s12916-015-0350-3.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

de Carvalho, A.C., Scapulatempo-Neto, C., Maia, D.C.C. et al. Erratum: Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma. BMC Med 13, 155 (2015) doi:10.1186/s12916-015-0406-4

Download citation